BigHat’s founders, CEO, Mark DePristo and CSO, Peyton Greenside were on the BIOS builders podcast hosted by Chris Ghadban from Alix Ventures. In this podcast, Mark and Peyton dive into a wide array of topics including the impetus behind founding BigHat, the challenges and opportunities of next generation antibodies, their role in fighting against today’s challenging diseases, BigHat’s unique platform that brings together synthetic biology, machine learning and automation and how BigHat is shifting drug discovery from ‘discovery’ to engineering.